Cannabis Report across cannabis plants
(Source: File image)

Canopy Growth has added new softgel capsules under its Spectrum Therapeutics medical cannabis brand in Australia in response to rising demand for product diversity. The softgels join Spectrum Therapeutics’ growing product suite, including oils and flower, in addition to flower under other Canopy Growth brands.

Cannabis softgels. (Source: Adobe Stock. Generated by AI)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 |  Planet 13 launches exclusive partnership to Bring ONI’s products to Florida

2 | Canopy Growth expands Spectrum Therapeutics portfolio in Australia with new softgels

3 |  Biorem reports record order backlog, $11.3 million of revenues in the quarter

4 | Decibel reports 37 per cent year over year net revenue increase of $32.9 million


Top Cannabis Stocks Nov. 14 to Nov. 19, 2025

1. T.TLRY | 4,1334views | Tilray Brands Inc.
2. T.LABS | 3,698 views | Medipharm Labs Corp.
3. T.CURA | 3,543 views | Curaleaf Holdings Inc.
4. T.WEED | 1,454 views | Canopy Growth Corp.
5. C.TGIF | 483 views | 1933 Industries Inc.
6. T.OGI | 432 views | Organigram Global Inc.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.



More From The Market Online

@ the Bell: Steady rates, rising gold weigh on markets as S&P hits milestone

Canada’s main stock index finished modestly higher on Wednesday as gold prices climbed to a new...

Bank of Canada holds key interest rate for second straight meeting

The Bank of Canada held its key interest rate at 2.25 per cent for a second straight meeting, a move analysts widely expected
The Market Online Video

Markets in Motion: Weaker dollar fuels commodity and small-cap rotation

In this Markets in Motion episode, Bruce Campbell explores U.S.dollar weakness, accelerating commodity prices, small-cap rotation, and shifting market leadership in early 2026.